Viridian Therapeutics has received FDA approval for Lumvoa, a treatment for thyroid eye disease (TED), and has begun treating patients. The company is now focusing on successfully launching Lumvoa and leveraging its commercial infrastructure for both Lumvoa and its investigational drug elegrobart. This strategy aims to improve operational efficiency and franchise economics. While the current valuation is high with no near-term asset-based safety net, future profitability depends on effective commercialization, reimbursement, and expense management. The outlook remains positive but requires close monitoring of launch progress and financial stability.
Viridian Therapeutics and its recent FDA approval for Lumvoa provide context for health sector activity. For readers following the health sector, here is Pluang's market snapshot as of Sep 17, 2026 21:11 WIB: Among 91 priced US health stocks tradable on Pluang, 59 rose and 31 fell today. Notable movers include Illumina, Inc. (ILMN) at USD 241.64 with a 1-day change of +5.55% and Pluang order activity of 97% Sell / 3% Buy, Ginkgo Bioworks Holdings Inc (DNA) at USD 7.44 with a 1-day change of +5.38%, and Citius Pharmaceuticals Inc (CTXR) at USD 0.58 with a 1-day change of +4.20% and Pluang order activity of 0% Sell / 100% Buy. Typical hold times on Pluang range from 11 to 86 days among these stocks.
Alignment Health Plan introduced Central Health Harmony, a new Medicare Advantage plan starting January 1, 2027, targeting Asian American seniors in Los Angeles and Orange counties. The plan offers access to over 600 physicians who speak Chinese, Kor...
NVIDIA and Cisco have introduced Ultra-Dense Small Form Factor Pluggable (USFP), a new optical module supporting 400Gb/s per lane, enabling up to 12.8Tb/s capacity for AI data centers. This technology doubles bandwidth per lane and increases power ef...
Hasbro announced the fourth annual Women Innovators of Play Design Challenge, accepting submissions from October 15 to November 20, 2026. The program now includes year-round in-person networking events alongside the design competition, aiming to conn...
Micas Networks introduced three new 102.4 Tbps open Ethernet switch platforms based on Broadcom Tomahawk 6 technology, designed to enhance AI factory networks. The portfolio includes air-cooled 800G, liquid-cooled 1.6T, and co-packaged optics (CPO) s...
Ferrari N.V. has repurchased 43,000 of its common shares on Euronext Milan as part of the third tranche of its multi-year €3.5 billion share buyback program announced in 2025. The recent purchases, totaling nearly €14.8 million, are part of a broader...
